AllDocs -> cancers

leukaemia LEUKAEMIA AND BLOOD FOUNDATION OF NEW ZEALAND TRAVEL GRANTS The Leukaemia and Blood Foundation invites applications for grants to support travel to meetings and workshops. The closing dates for applications will be: 20 June 2004 30 September 2004 Applications must be forwarded by a closing date prior to the time of the intended travel. Application forms should be returned to: Administration Manager Leukaemia and Blood Foundation PO Box 99 182 Newmarket AUCKLAND 1031 LEUKAEMIA AND BLOOD FOUNDATION OF NEW ZEALAND PO BOX 99 182,NEWMARKET, AUCKLAND 1031 APPLICATION FOR TRAVEL FUNDS (SIX TYPED COPIES REQUIRED) PART A 1. Title: Sur...

EBMT European Group for Blood and Marrow Transplantation MED-B FORM ACUTE LEUKAEMIA For registration of ALLOGENEIC or AUTOLOGOUS Stem Cell Transplantation The specific questionnaire for each disease has been established by the responsible working party. Any request for modification and improvement should be first discussed at the level of the working party which will then transmit approved modifications to the EBMT registry sub-committee Copyright © by EBMT, 2003 All rights reserved Page 2 EBMT - MED B 2003 – ACUTE LEUKAEMIA - p. 1 INSTRUCTIONS FOR USE.2 G ENERAL I NFORMATION . 4 A CUTE L EUKAEMIA .. 5 F OLLOW UP : P RIMARY L EUKAEMIAS ...

EBMT European Group for Blood and Marrow Transplantation MED-B FORM CHRONIC MYELOID LEUKAEMIA For registration of ALLOGENEIC or AUTOLOGOUS Stem Cell Transplantation The specific questionnaire for each disease has been established by the responsible working party. Any request for modification and improvement should be first discussed at the level of the working party which will then transmit approved modifications to the EBMT registry sub-committee Copyright © by EBMT, 2003 All rights reserved Page 2 EBMT - MED B 2003 – CML - p. 1 INSTRUCTIONS FOR USE 2 G ENERAL I NFORMATION . 4 C HRONIC M YELOID L EUKAEMIA .. 5 F OLLOW UP : L EUKAEMIAS ...

LEUKAEMIA CLUSTERS Occasional Papers No 1. Occasional Papers is a series of short publications. which address topics of current concern or other wide public interest and which have been written for the non-specialist reader. ©1995 - The Royal Society of Edinburgh Published by the Leukaemia Research Fund with the kind permission of the Royal Society of Edinburgh Introduction and Summary Defining & Describing Clusters Statistical Principles British experience in the detection of human leukaemia clusters German experience in the observation of childhood leukaemia clusters The Nature & Possible Causes of Leukaemia Genetic Conspiracy Ionising Occasional Papers may be based on and published soon ...

Clinical trials supported by Leukaemia Research Fund Phase I/II A Phase I/II feasibility study of peptide vaccination in chronic myeloid leukaemia ; Acronym: EPIC (Dr R Clark) The leukaemia cells in patients with chronic myeloid leukaemia have a protein marker on their surface that is made of parts of the BCR-ABL onco-protein. These markers can be recognised by the immune system, which in turn can mount a reaction and destroy these malignant cells. Unfortunately, the immune reaction can be very weak and sometimes does not occur at all. The aim of this study is to use BCR-ABL peptides, produced in the laboratory and vaccinate patients with them in order to enhance the immune response and hopefully destroy the leukaemia cells. Principal Investigator: Dr R E Clark Royal Liverpool University Hospital Prescot Street Liverpool Phase II study of the tolarability of the ...

M yeloma is a life-threatening cancer of the blood, similar to leukaemia or lymphoma. It is caused when one type of blood cell, called a plasma cell, grows in uncontrolled numbers. Plasma cells, which grow in the bone marrow at the centre of many of our bones, play a vital role in our immune system, producing proteins which attack foreign bodies such as bacteria and other organisms. Unlike leukaemia where the tumour cells spill out into the blood, malignant myeloma cells accumulate in the bones. This build- up is most commonly found in bones closest to sites of the most active blood-forming bone marrow, such as the pelvis, spine and skull. The skeleton is not a static structure. Bone is continuously being formed and broken down again throughout life. Unfortunately, myeloma cells upset this fine balance which can lead to painful and debilitating bone damage which is such a distressing feature ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Referees & Futsal Officer REPORTS TO: Soccer Operations Co-ordinator CURRENT INCUMBENT: VACANT DIRECT REPORTS: n/a AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. Referees ...

IJTCVS Karthik et al 93 2004; 20: 93–94 AML after oesophagectomy Chest radiograph revealed diffuse bilateral fluffy shadows. He also developed atrial fibrillation which responded to cardioversion and amiodarone. Despite various interventions his condition continued to deteriorate over the next two days. He developed renal failure and required haemofiltration. He developed pyrexia with a steep rise in the white blood count. From a pre-operative level of 11.0 x10 6 /ml, the white cell count rose to 27.5 on the first post- operative day and from thereon in a dramatic fashion to 69, 99, 149.7 and finally to over 250 x10 6 /ml. Initially, this was considered as a response to sepsis. However, as the rise continued, the possibility of leukaemoid reaction or acute leukaemia were considered. His peripheral smears were reviewed. The preoperative ...

Aetiology of Childhood Leukaemia Tracy Lightfoot Epidemiology & Genetics Unit Page 2 Childhood Cancer 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% leukaemia brain lymphoma soft tissue sarcoma neuroblastoma kidney bone germ cell retinoblastoma epithelial liver other Page 3 What is Leukaemia ? • Leukaemia is a clonal disease originating in a single cell • It evolves by the accrual of mutations within a clone resulting in genetic diversification • Dominant mutant subclones are then naturally selected • The nature of the clone and how far it has evolved determines the clinical outcome • Delay in diagnosing increases the likelihood that the clone will have ...

LEUKAEMIA TARGET 44643 ABPI Target Leukaemia 13/5/04 8:46 Page 1 Page 2 The Association of the British Pharmaceutical Industry 12 Whitehall London SW1A 2DY Telephone: 020 7930 3477 Fax: 020 7747 1411 E-mail: abpi@abpi.org.uk Website: www.abpi.org.uk Researched and written by Dr Mike Hall Target Series Editor: Bill Kirkness Acknowledgements The ABPI wishes to thank member companies for the help given in the preparation of this booklet. We are also indebted to Leukaemia Care for their helpful advice and comments on the draft text. In particular, we are grateful to Dr Charles Stiller of the Childhood Cancer Research Group, University of Oxford, for the graphs showing survival in childhood leukaemia , and to the UK Child Cancer Study Group for the figure of overall survival in children. ...

Australian Dental Journal 2003;48:3. 195 Acute leukaemia presenting as oral ulceration to a dental emergency service AK Dean,* JW Ferguson,† ES Marvan‡ Abstract Leukaemia is a neoplastic disease characterized by an excessive proliferation of immature white blood cells and their precursors. Oral lesions may be the presenting feature of acute leukaemias, which can be rapidly fatal if left untreated. This report describes the case of a 22-year-old female who presented to a dental emergency department with oral manifestations of acute leukaemia . It outlines the role of oral lesions in the diagnosis of acute leukaemias and emphasizes the importance of immediate referral by general dental practitioners. Key words: Acute leukaemia , oral ulceration, oral manifestations. (Accepted for publication 9 November 2001.) The leukaemias are subdivided ...

Our research programme funds more than 120 projects at universities and hospitals across the UK, and we need £20 million a year to keep making progress in the fight against these deadly diseases. Our research is innovative and exciting, involving DNA, molecular biology, gene therapy, cutting-edge technology and more. Our goal is to ensure that everyone with leukaemia and the other blood cancers makes a full recovery. LEUKAEMIA R E S E A R C H Animal experiments, medical advances and Leukaemia Research Leukaemia Research Fund 43 Great Ormond Street London WC1N 3JJ Registered Charity 216032 020 7405 0101 www.lrf.org.uk The aim of our research is to conquer life-threatening diseases and alleviate suffering. What is leukaemia ? Leukaemia is often referred to as blood cancer. It occurs when massive numbers of rogue ...

D A N I S H M E D I C A L B U L L E T I N V O L . 5 1 N O . 2 7 / M A Y 2 0 0 4 223 ABSTRACT OF PhD DISSERTATION Aspects of the natural history of childhood leukaemia Lisa Lyngsie Hjalgrim This PhD dissertation was accepted by the Faculty of Health Sciences of the University of Copenhagen, and defended on March 19, 2004. Official opponents: Mikael Rørth, Jørgen H. Olsen, and Steen Rosthøj. Supervisors: Kjeld Schmiegelow and Mads Melbye. Correspondence: Lisa Lyngsie Hjalgrim, Søvangs Alle 12, DK-3500 Værløse. E-mail: lih@ssi.dk Dan Med Bull 2004;51:223. ABSTRACT The studies included in this PhD dissertation were carried out at the Department of Epidemiology Research, Statens Serum Institut, and focus on characterising the occurrence of childhood leukaemia , tim- ing of critical genetic events involved ...

Haema 2004; 7(3): 374-377 Case report Bacterial pyomyositis in a patient with adult acute lymphoblastic leukaemia Zeynep Aki, Simten Dagdas, Ayla Gokmen Akoz, Zeynep Erdin Erdem, Mehmet Yilmaz, Nil Guler, Meltem Ayli, Guchan Alanoglu 1 , Gulsum Ozet Ankara Numune Education and Research Hospital, Ankara, 1 Suleyman Demirel University, Department of Haematology, Isparta, Turkey Abstract. Pyomyositis is an acute bacterial infection of skeletal muscle, most commonly seen in tropical countries. Staphylococcus aureus is the principal cause of pyomyositis. Although pyomyositis is a rare disorder in other areas, there is an increasing frequency to-date due to the increase in immunocompromised patients. The combination of myalgia, fever and muscle tenderness provides early evidence for the diagnosis of pyomyositis in neutropenic patients after chemotherapy. ...

Leukaemia Busters The Children’s Leukaemia Research Charity 2004 A Purbeck Odyssey Walking towards a Cure for ALL To boldly tread where only some men, women and children have been before Corfe Castle and beyond Saturday 26 June Picture by Andrew P M Wright Registration form part 2 Registration fees: Qty sub-total ? Castle Walk Adults at £6.00 each Young adults (12–16 years) at £3.00 each .. Children (under 12 years) at £2.00 each .. ? Whale Walk (Fee includes train fare) Adults at £10.00 each. Young adults (12–16 years) at £6.00 each .. Children (under 12 years) at £5.00 each .. ? Dolphin Walk (Fee includes train fare) Adults at £10.00 each Young adults (12–16 years) at £6.00 each .. ? Purbeck Voyage Adults at £6.00 each ...

A ABC LEUKAEMIA RESEARCH FUND CLINICIAN SCIENTIST AWARDS 2005 The Leukaemia Research Fund in partnership with the Academy of Medical Sciences is pleased to invite applications for two 4-year Clinician Scientist posts to begin on 1st January 2005 or as soon as possible thereafter. These prestigious awards are part of a national scheme to promote recruitment into clinical academic medicine. The purpose of the awards is to combine the completion of specialist training in haematology with post-doctoral research in an approved laboratory. Entry to the scheme will be at SpR level MRC Path Part I and candidates will have completed a PhD/DPhil or expect to have received their doctorate prior to taking up an award. The posts must be supernumerary to existing SpR rotations and offer a flexible programme of training integrated with protected research time. Candidates must have a proven record of ...

Addenbrooke’s NHS Trust: Consent Form Publisher: Risk Management, Box 243, Addenbrooke’s NHS Trust, Hills Road, Cambridge CB2 2QQ; Tel: 01223 245 151 Date: 29 September 2003 Review Date: October 2004 File: CFPI280 Page 1 of 5 Paediatric Oncology Unit Information Sheet For Parents of a Child who has Leukaemia Routine procedures under general anaesthetic for the whole course of leukaemia treatment Lumbar puncture (to obtain samples of cerebrospinal fluid - CSF) Intrathecal chemotherapy (part of leukaemia treatment) Bone marrow aspirate (to sample the bone marrow using a smaller or larger needle) These procedures are usually carried out as day-case procedures in the Paediatric Day Unit at Addenbrooke’s Hospital You will be asked to read this form carefully and you and your doctor (or another health professional) will sign it with you to document ...

Periodic chronic myelogenous leukaemia : spectral analysis of blood cell counts and aetiological implications P A S C A L F O RT I N A N D M I C H A E L C. M AC K E Y * Departments of Physiology and Physics and * Departments of Physiology, Physics and Mathematics, Centre for Nonlinear Dynamics, McGill University, Montreal, Canada Received 23 June 1998; accepted for publication 23 October 1998 Summary. Of 24 published clinical reports of periodic chronic myelogenous leukaemia (PCML), 21 had sufficient data to analyse for periodicity, and 12 showed significant periodicity ( p 0·05) using the Lomb periodogram. Leuco- cyte oscillations had periods T ranging from 37 to 83 d. When data were also reported for platelets and reticulocytes there was no significant difference between their periods and those of the ...

March 2004 151 139 228 72 PB 359 155 580 74 PB 36 8 65 4 BM + PB 565 236 1635 381 BM 3 3 1 1 BM + PB 1142 145 2644 82 PB HLA identical Sibling ALLO AUTO Family Mismatch Unrelated Donor 119 326 112 131 Unrelated CB * 30 19 26 6 BM + PB 100 117 120 38 BM 909 990 988 253 BM 1534 1187 2706 584 BM 95 12 397 24 BM + PB 1165 320 3378 216 PB ADULTS CHILDREN ADULTS CHILDREN ...

This booklet is for you if you or someone close to you has Acute Lymphoblastic Leukaemia (ALL). The information in this booklet represents an agreed view on ALL, its diagnosis and management, and the key aspects of living with it. It has been prepared and checked by doctors, other relevant specialists, nurses and patients. The booklet had been designed so it can be used by many hospitals but each hospital may have its own guidelines or restrictions that are not mentioned here. Please ask your own doctor or nurse if you have any questions. If you are a patient, your doctor or nurse may wish to go through this booklet with you and mark sections that are particularly important for you. You can make a note below of the contact names and information that you may need quickly. Acute Lymphoblastic Leukaemia Understanding Specialist nurse/contact names Hospital Phone Treatments ...

leukaemia Myelodysplastic syndrome and acute myeloid leukaemia Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University of Hong Kong Leukaemia classification FAB MIC 1987 EGIL 1996 REAL Proposed by ILSG in 1994 Lymphoma classification, but principles extended to other haemic neoplasms Encompasses all available information Consensus approach WHO Classification Collaborative project of: European Association for Haematopathology Society for Haematopathology Started in 1995 Steering Committee Working Group Meeting in Lyon, France, November 8 – 11, 2000 Clinical Advisory Committee Myelodysplastic syndrome A group of clonal haemopoietic stem cell disorder characterized by dysplasia and ineffective ...

abc H o d g k i n ’s disease & other lymphomas myeloma • myelodysplasia • aplastic anaemia the myeloproliferative disorders • the leukaemias Page 2 Acknowledgements The Leukaemia Research Fund gratefully acknowledges the help and advice of Professor A. V. Hoffbrand in reviewing this series of publications and the assistance of Professor A. Burnett, Professor D. C a t o v s k y, Professor J. Chessells, Professor J. Goldman, Professor E. Gordon-Smith, Professor A. Green, Dr A. Haynes, Professor G. Morg a n , Dr S. O'Brien, Professor J. Sweetenham and Professor J.L. Yin in the preparation of specific titles. Published by Leukaemia Research Fund , April 2001 43 Great Ormond Street L o n d o n WC1N 3JJ Tel: 020 7405 0101 Email: info@lrf.org . u k Fax: 020 7242 1488 Web: www. l r f . o rg . u k Registered Charity 216032 ...

For more information on leukaemia or the Leukaemia Foundation, visit www. leukaemia .com WHO WE ARE The Leukaemia Foundation, a progressive national non-profit organisation, is dedicated to the support of people with leukaemia , lymphoma, myeloma, aplastic anaemia and related blood disorders. The Foundation has two clear objectives – (1) to improve the lives of the 17 Australians, on average, who are diagnosed with leukaemia * and related blood disorders every day, and (2) to contribute in every way possible to finding a cure for this group of cancers. Caring today The Leukaemia Foundation does this by providing support and counselling, accommodation, education, patient transportation and other practical assistance for patients and their families. Currently, the Leukaemia Foundation’s national team of over 20 support staff personally handles approximately ...

MEDIA RELEASE MEDIA LINK - The World's Greatest Shave for a Cure website has a dedicated media page, which can be accessed from the home page at www.worldsgreatestshave.com Here, you can find out more information about WGS and the Leukaemia Foundation, media releases and download WGS images in print-ready format. AUSSIES PUT THEIR HAIR ON THE LINE FOR LEUKAEMIA WORLD’S GREATEST SHAVE FOR A CURE - 12-13 MARCH 2004 Australians are campaigning against leukaemia with more than 10,000 already registered to shave or colour their hair in the Leukaemia Foundation’s World’s Greatest Shave for a Cure ( WGS) on 12-13 March 2004. Sponsored by Triple M, WGS 2004 is the Leukaemia Foundation’s biggest annual fundraising event, and this year 35,000 Queenslanders are expected ...

MEDIA RELEASE MEDIA LINK - The World's Greatest Shave for a Cure website has a dedicated media page, which can be accessed from the home page at www.worldsgreatestshave.com . Here, you can find out more information about WGS and the Leukaemia Foundation, media releases and download WGS images in print-ready format. Friday 27 February 2004 For immediate release AUSSIES PUT THEIR HAIR ON THE LINE FOR LEUKAEMIA WORLD’S GREATEST SHAVE FOR A CURE – 12-13 MARCH 2004 Australians are campaigning against leukaemia with more than 10,000 already registered to shave or colour their hair in the Leukaemia Foundation’s World’s Greatest Shave for a Cure ( WGS) on 12-13 March 2004. World’s Greatest Shave for a Cure 2004 is the Leukaemia Foundation’s biggest annual fundraising event, and this year 1,000 Tasmanians are expected to participate ...

MEDIA RELEASE MEDIA LINK - The World's Greatest Shave for a Cure website has a dedicated media page, which can be accessed from the home page at www.worldsgreatestshave.com . Here, you can find out more information about WGS and the Leukaemia Foundation, media releases and download WGS images in print-ready format. Friday 27 February 2004 For immediate release AUSSIES PUT THEIR HAIR ON THE LINE FOR LEUKAEMIA WORLD’S GREATEST SHAVE FOR A CURE – 12-13 MARCH 2004 Australians are campaigning against leukaemia with more than 10,000 already registered to shave or colour their hair in the Leukaemia Foundation’s World’s Greatest Shave for a Cure ( WGS) on 12-13 March 2004. Sponsored by Triple M, World’s Greatest Shave for a Cure 2004 is the Leukaemia Foundation’s biggest annual fundraising event, and this year 10,500 Victorians are expected ...